GDTC
CytoMed Therapeutics·NASDAQ
--
--(--)
--
--(--)
2.64 / 10
Underperform
The technical composite registers 2.64/10, evidencing challenging technical structure. Supportive evidence from MACD Death Cross contends with contradictory data from Marubozu White and Long Lower Shadow. Technical evaluation: cautious.
Analysis Checks(1/3)
Long Lower Shadow
Score1.41/10
Win Rate43.40%
Hist. Signals53
Avg Return-1.19%
Score1.41/10
Win Rate43.40%
Hist. Signals53
Avg Return-1.19%
Marubozu White
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-1.90%
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-1.90%
MACD Death Cross
Score5.5/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.07%
Score5.5/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.07%
Long Lower Shadow
Score1.41/10
Win Rate43.40%
Hist. Signals53
Avg Return-1.19%
Score1.41/10
Win Rate43.40%
Hist. Signals53
Avg Return-1.19%
MACD Death Cross
Score5.5/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.07%
Score5.5/10
Win Rate57.14%
Hist. Signals14
Avg Return-0.07%
Marubozu White
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-1.90%
Score1/10
Win Rate36.17%
Hist. Signals47
Avg Return-1.90%
Technical Analysis of GDTC?
- GDTC presents a Underperform setup with a Technical Score of 2.64/10. Key technical indicators highlight an RSI of 42.26 and a MACD of -0.01, with the trend anchored by the 50-Day SMA at 1.02. Traders should monitor key support at 1.00 and resistance at 1.00.
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
